Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system M. M. S. StahlM. LindquistJ. S. Schou PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 163 - 169
Self-reported medication non-compliance in the elderly J. C. McElnayC. R. McCallionM. Scott PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 171 - 178
Relationship between drug use and self-reported health in elderly Danes J.-U. RosholmK. Christensen PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 179 - 183
Use of lipid-lowering drugs from 1990 to 1994: an international comparison among Australia, Finland, Italy (Emilia Romagna Region), Norway and Sweden N. MagriniT. EinarsonU. Bergman PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 185 - 189
Asthma education for Swedish primary care physicians – a study on the effects of "academic detailing" on practice and patient knowledge Y. TomsonJ. HasselströmH. Åberg PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 191 - 196
Amlodipine lowers blood pressure without increasing sympathetic activity or activating the renin-angiotensin system in patients with essential hypertension M. SasaguriN. MatsumotoK. Arakawa PHARMACODYNAMICS Pages: 197 - 201
The clinical relevance of the interaction between carbamazepine and dextropropoxyphene in elderly patients in Gothenburg, Sweden L. BergendalA. FribergS. Landahl CLINICAL TRIALS Pages: 203 - 206
Adverse events and discomfort in studies on healthy subjects: the volunteer's perspective A survey conducted by the German Association for Applied Human Pharmacology R. HermannD. Heger-MahnC. de Mey CLINICAL TRIALS Pages: 207 - 214
Single-dose pharmacokinetics of temocapril and temocapril diacid in subjects with varying degrees of renal impairment B. SierakowskiK. PüchlerI. Roots PHARMACOKINETICS AND DISPOSITION Pages: 215 - 220
Pharmacokinetics and pharmacodynamics of candesartan after administration of its pro-drug candesartan cilexetil in patients with mild to moderate essential hypertension – a population analysis I. MeinekeH. FeltkampU. Gundert-Remy PHARMACOKINETICS AND DISPOSITION Pages: 221 - 228
The novel anti-migraine compound zolmitriptan (Zomig 311C90) has no clinically significant interactions with paracetamol or metoclopramide E. J. SeaberG. RidoutR. W. Peck PHARMACOKINETICS AND DISPOSITION Pages: 229 - 234
Polymorphic CYP2D6 mediates O-demethylation of the opioid analgesic tramadol W. D. PaarS. PocheH. J. Dengler PHARMACOKINETICS AND DISPOSITION Pages: 235 - 239
Low-dose aspirin decreases blood alcohol concentrations by delaying gastric emptying S. KechagiasK.-Å. JönssonA. W. Jones PHARMACOKINETICS AND DISPOSITION Pages: 241 - 246
Lack of bioavailability of mebeverine even after pretreatment with pyridostigmine D. K. SommersJ. R. SnymanJ. N. Eloff PHARMACOKINETICS AND DISPOSITION Pages: 247 - 249
Penetration of ciprofloxacin, norfloxacin and ofloxacin into the aqueous humour of patients by different topical application modes J. von KeyserlingkR. BeckB. Drewelow PHARMACOKINETICS AND DISPOSITION Pages: 251 - 255
Debrisoquine and S -mephenytoin hydroxylation polymorphisms in a Russian population living in Estonia T. MarandiM.-L. DahlF. Sjöqvist PHARMACOKINETICS AND DISPOSITION Pages: 257 - 260
The hydroxylation of omeprazole correlates with S-mephenytoin and proguanil metabolism S. KortunayN. E. BasciS. O. Kayaalp PHARMACOKINETICS AND DISPOSITION Pages: 261 - 264
The character of inhibition of the metabolism of 1,2-benzopyrone (coumarin) by grapefruit juice in human M. RunkelM. BourianW. Legrum PHARMACOKINETICS AND DISPOSITION Pages: 265 - 269
Slow elimination of mannitol from human cerebrospinal fluid R. NauH. DeselH. W. Prange PHARMACOKINETICS AND DISPOSITION Pages: 271 - 274
Free circulating magnesium and loop diuretics in humans T. GozziS. DürlerM. G. Bianchetti LETTER TO THE EDITORS Pages: 275 - 276
Simvastatin reduces activation of normal platelets by LDL isolated from patients with familial hypercholesterolaemia and familial defective apolipoprotein B D. A. TsakirisU. KellerG. A. Marbet Letter to the editors Pages: 277 - 279
Adjuvant cyclophosphamide, methotrexate and fluorouracil for node-positive breast cancer: a lifetime cost–utility analysis based on a modified Q-TWIST method S. TrippoliP. BecagliA. Messori LETTER TO THE EDITORS Pages: 281 - 282
Reply to the letter to the editors by P. Zanen A. J. M. Schreurs LETTER TO THE EDITORS Pages: 285 - 286
